Global Group is a healthcare-focused international development and consulting company. Oral Genome’s test aims to enhance early detection by evaluating risks for dental caries, periodontal disease, halitosis and diabetes.
Through this pilot initiative, the companies will deploy Oral Genome’s salivary test kit in regions that traditionally lack adequate care, including in the U.S., EMEA, South Asia and Central Asia, according to a May 24 news release. The project ultimately aims to create models that reduce oral health disparities and document the impact of integrated technologies.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
